Advertisement
X

Malaria Gains, But Gaps Remain

President Droupadi Murmu and Union Health Minister J.P. Nadda release a commemorative malaria stamp as India targets elimination by 2030.

President Droupadi Murmu and Union Health Minister J.P. Nadda release a commemorative malaria stamp

India has cut malaria cases and deaths by nearly 80% in a decade, but two recent studies underline why the final push towards elimination will require better surveillance in vulnerable communities and treatment that patients can complete.

The findings come at a significant moment for the country’s malaria programme. President Droupadi Murmu on Tuesday inaugurated the year-long golden jubilee celebrations of the Indian Council of Medical Research’s National Institute of Malaria Research (ICMR-NIMR), which was established in 1977.

Addressing the gathering, the President said malaria cases and deaths had declined by nearly 80% between 2015 and 2025, while the number of high-burden districts had fallen from 155 to 33. As many as 160 districts reported zero indigenous malaria cases during 2022-2025.

She, however, called for sustained vigilance, stronger surveillance and greater community participation, stressing that scientific research must reach villages and communities where it is most needed. Recalling her own experience of seeing the disease affect rural communities, she said malaria had consequences beyond health, disrupting livelihoods, education and people's futures.

Union Health Minister J. P. Nadda said India was confident of eliminating malaria by 2030. “We will eliminate malaria by 2030 by bringing about the necessary changes in our strategies and policies,” he said, calling for renewed efforts by ICMR-NIMR.

The need for such vigilance is evident in an investigation published in Malaria Journal on October 3, 2026. It documented a malaria outbreak in an informal settlement in Rajasthan, a state classified as having low malaria transmission.

The investigation followed the deaths of three children from the same family in November 2024 in a settlement on the outskirts of a village in Sirohi district. Two children died at home without receiving treatment, while the third died in hospital.

The team identified 21 confirmed malaria cases among 752 residents, including 18 caused by Plasmodium falciparum and three by Plasmodium vivax. Three of the 21 patients died, giving the outbreak a case fatality rate of 14.3%.

The investigation exposed serious gaps in access to basic public-health services. The settlement had not been mapped for routine health surveillance and was excluded from preventive activities such as fever surveys and vector-control measures. The nearest health facility had a non-functional microscope, and laboratory staff were not adequately trained to identify malaria parasites. Poor-quality blood slides also made reliable diagnosis difficult.

Advertisement

Most patients reportedly slept outdoors without mosquito nets. The findings suggest that low transmission at the state level can conceal localised risks, particularly among communities that remain outside routine surveillance.

The study, titled Malaria in an informal settlement of a socioeconomically disadvantaged population in Rajasthan, a non-endemic state of India, 2024: an epidemiological investigation, was conducted by public-health and entomology teams from the India Epidemic Intelligence Service Cell and Entomology Division of the National Centre for Disease Control, along with the South Asia Field Epidemiology and Technology Network and the Rajasthan health department. The researchers included Pankaj Kumar Taylor, Ramkesh Choudhary, Srividya K. Vedachalam, Sushma Choudhary, Arun Chauhan, Shweta Sharma, Praveen Aswal & Arti Bahl.

A second study, involving ICMR-NIMR researchers, points to another challenge in malaria control — ensuring that patients complete treatment and are protected against relapse.

Published in The Lancet Regional Health – Southeast Asia in October 2026, the randomised controlled trial compared a seven-day course of primaquine with the standard 14-day course for treating P. vivax malaria. The parasite can remain dormant in the liver and cause relapses months after the initial infection.

Advertisement

The trial enrolled 400 patients at two Indian sites — Calcutta National Medical College in Kolkata and a centre in Ahmedabad. Both groups received the same total primaquine dose of 3.5 mg per kg, but over different durations.

During 180 days of follow-up, four patients had a recurrence of malaria — two in each group. The recurrence rate was 1.1% in both groups. However, adherence was better with the shorter course: 8% of patients in the seven-day group missed a dose, compared with 20% in the 14-day group.

The researchers found the seven-day regimen to be non-inferior to the 14-day schedule during the follow-up period and well tolerated among patients with normal G6PD activity. They cautioned that the small number of recurrences limited the precision of the findings and that longer follow-up would help assess late relapses.

The study was a collaboration involving ICMR-NIMR, the Infectious Diseases Data Observatory at the University of Oxford and the Menzies School of Health Research, among other institutions. Dr Rajendra Kumar Baharia and colleagues led the research.

Advertisement

Together, the studies highlight two different but connected priorities for malaria elimination: reaching people who are missed by routine health services and ensuring that those diagnosed receive treatment they can complete.

In 2024, there were an estimated 2.7 million malaria cases and 3900 deaths in the World Health Organization’s South-East Asia Region (WHO-SEAR), of whom India accounted for 73% of cases and 89% of deaths.

India has achieved an impressive 70% reduction in malaria incidence and mortality, from 2015 to 2024, and exited the High-Burden to High-Impact (HBHI) group in 2024.

However, areas of high transmission remain in districts (sub-state administrative units), consisting of hilly, tribal (indigenous), forested and conflict-affected regions which account for approximately 80% of its cases.

India aims to achieve zero indigenous malaria cases by 2027 and eliminate the disease by 2030. The President also pointed to emerging threats such as climate change, unplanned urbanisation and growing insecticide resistance among mosquitoes.

Advertisement

Preventing waterlogging, removing breeding sites and strengthening environmental management will therefore remain important, she said.

Published At:
US